ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000028 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
21,167
Total Value
$2,157,542.21
P&L
+inf% (+$4,435,623.53)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 12, 2026 | Grant/Award | 14,209 | $0.00 | $0.00 | 92,620 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 13, 2026 | Sale | 6,958 | $310.08 | $2,157,542.21 | 85,662 | Direct | โ | View Details |